Why Are Lonmin Plc, Oxford BioMedica plc & Bango plc Among Today’s Biggest Gainers?

Should you buy or sell these 3 major gainers? Lonmin Plc (LON: LMI), Oxford BioMedica plc (LON: OXB) and Bango plc (LON: BGO)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in Lonmin (LSE: LMI) have soared by over 5% today after the mining company announced the appointment of a new CFO. Barrie van der Merwe will take over on 17 May and the market seems to have welcomed this prompt decision by the company following the resignation of Simon Scott.

Clearly, this is a time of major change for Lonmin as it seeks to implement an updated strategy in response to exceptionally difficult trading conditions. As part of this, it is restructuring its business and also seeking to cut costs; both of which are likely to have a positive impact on Lonmin’s bottom line over the medium to long term. And with Lonmin having the capital through which to effect its new plan following last year’s fundraising, its future seems to be brighter than it was just a handful of months ago.

This increased confidence plus a more stable commodity price environment has led to a rise in Lonmin’s share price of 99% since the turn of the year. This rapid increase could continue, although Lonmin remains a relatively high risk play and may only be of interest to less risk averse investors.

Also rising today are shares in Oxford BioMedica (LSE: OXB), with them being up over 11% despite no significant news flow having been released by the company today. In fact, the gene therapy specialist has not released an update since 7 March when it announced a new and expanded collaboration with Immune Design Corp. Since then its shares have fallen by around 6% but looking ahead, the company has clear potential to deliver profitability.

The challenge for investors, though, is that profitability may still be a long way off. And in the meantime Oxford BioMedica is in a cash burn phase which could require further fundraisings following its £8.1m placing in February. As such, and while Oxford BioMedica has a bright long term future in a very appealing space, it may only be worth a closer look for less risk averse investors.

Meanwhile, shares in mobile payments company Bango (LSE: BGO) have risen by 12% today despite a lack of news flow. Despite this, its shares have still fallen by 60% since the turn of the year even though Bango’s full-year results have showed that it is making progress. For example, it experienced significant growth in end user spend, with the company also doubling the rate of spending through the Bango payment platform. And with a stable cost base, it seems to be well-positioned to move towards profitability.

Of course, the market seems to be somewhat downbeat on Bango’s prospects judging by its recent share price fall. While today’s upward movement could indicate a change in sentiment, it may be prudent to await confirmation of this over the medium term before piling in.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Down 45% in 5 years, this UK stock now offers a stunning 11% dividend yield!

Among the highest UK dividend yields, one immediately begs for closer inspection. Can this double-digit marvel really pull it off?

Read more »

Middle-aged black male working at home desk
Investing Articles

Here’s how Aviva shares could soon rise a further 20%… or fall 15%!

Aviva shares have fallen back a bit, with Q1 results due in May. But analysts are mostly optimistic, and see…

Read more »

Dominos delivery man on skateboard holding pizza boxes
Investing Articles

£5,000 invested in high-yield FTSE 250 stock Domino’s Pizza on 7 April is now worth…

Anyone who put £5,000 into FTSE stock Domino’s Pizza after the Easter break would now be laughing as its share…

Read more »

Tesla building with tesla logo and two teslas in front
Investing Articles

Tesla stock’s up 50% in a year. Could it go even higher?

This week saw Tesla announce mixed first-quarter results. Yet Tesla stock's worth half as much again as a year ago.…

Read more »

Businessman hand stacking up arrow on wooden block cubes
Investing Articles

Up 9% today, is this FTSE 250 share’s recovery gaining pace?

This FTSE 250 share has had a welcome boost in the market today after it unveiled an upbeat trading statement.…

Read more »

Lady wearing a head scarf looks over pages on company financials
Investing Articles

5 years ago Barclays shares cost just 181p! Are they still a buy at today’s 434p?

Harvey Jones says investors have to pay a lot more to buy Barclays shares than just a few years ago,…

Read more »

Tanker coming in to dock in calm waters and a clear sunset
Investing Articles

Up 36%, could Shell shares still offer value for the long term?

Christopher Ruane has owned Shell shares before -- and got burnt by a dividend cut. Could recent oil price rises…

Read more »

A young Asian woman holding up her index finger
Investing Articles

£5,000 invested in FTSE 100 stock London Stock Exchange Group 1 month ago is now worth…

FTSE 100 powerhouse London Stock Exchange Group has been dragged into the software sell-off. However, recently, it has started to…

Read more »